[Research progress of immunotherapy alone and in combination for liver cancer].

Wu, Z J L; Li, K; Zhang, K; Gong, W D

Wu, Z J L; Li, K; Zhang, K; Gong, W D.

Afiliación

Wu ZJL; Department of General Surgery, Yixing Cancer Hospital, Wuxi 214205, China.
Li K; Department of General Surgery, Yixing Hospital Affiliated to Jiangsu University, Wuxi 214200, China; Department of General Surgery, People's Hospital of Yixing City, Wuxi 214200, China.
Zhang K; Department of General Surgery, Yixing Hospital Affiliated to Jiangsu University, Wuxi 214200, China; Department of General Surgery, People's Hospital of Yixing City, Wuxi 214200, China.
Gong WD; Department of General Surgery, Yixing Hospital Affiliated to Jiangsu University, Wuxi 214200, China; Department of General Surgery, People's Hospital of Yixing City, Wuxi 214200, China.

Zhonghua Gan Zang Bing Za Zhi ; 28(6): 471-474, 2020 Jun 20.

Article en Zh | MEDLINE | ID: mdl-32660173

Asunto(s)

Carcinoma Hepatocelular; Inmunoterapia; Neoplasias Hepáticas; Carcinoma Hepatocelular/terapia; China; Humanos; Neoplasias Hepáticas/terapia; Calidad de Vida

Palabras clave

Combination therapy; Hepatocellular carcinoma; Immune checkpoint inhibitors; Immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Inmunoterapia / Neoplasias Hepáticas Aspecto: Patient_preference Límite: Humans País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google